PubRank
Search
About
An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France
Clinical Trial ID NCT02979769
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02979769
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.
Nat Med
2011
2.40
Next 100